Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. - Wikidata - awgldk - TriplyDB

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

http://www.wikidata.org/entity/Q35794363

about

Claudin 1 in Breast Cancer: New Insights Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis Unraveling the microenvironmental influences on the normal mammary gland and breast cancer Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays.Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.Rare breast cancer subtypes: histological, molecular, and clinical peculiarities Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases.Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.Management options in triple-negative breast cancer Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.A gene signature for predicting outcome in patients with basal-like breast cancer.Basal-like breast cancer: molecular profiles, clinical features and survival outcomes Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer Early onset of breast cancer in a group of British black women Immunophenotypic and genomic characterization of papillary carcinomas of the breast.Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.Identification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology.Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast.Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions.Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.Breast carcinoma--rare types: review of the literature.Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.Histological types of breast cancer: how special are they?Triple-negative breast cancer: present challenges and new perspectives.Beyond triple-negative breast cancer: the need to define new subtypes.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.

P2860

Q26774988-C83C61C9-3E18-4DD8-AB8B-45AC48763C10 Q26776018-2B40B252-6ADF-4025-B61B-E1F81129711D Q28473677-9AF943A5-2077-4CC0-AF38-91A966D6C763 Q28741460-BF08F4DC-591A-4B1F-9D12-529A191C7740 Q33570282-A6C657AD-A534-4DB3-BD2A-317E2EF6F491 Q33607569-7DFF09F1-D75D-4FCD-930A-9B0C2473E4F2 Q33627191-AAE9742D-FD1B-4953-88CD-C684C955388C Q33751806-08F363E7-284C-46BA-B939-8C091C47F4EA Q34005143-719CE209-911B-4CAA-82C4-02FB7162D6EB Q34248718-497480DA-83B7-4B2D-AF9D-CE0A7F393818 Q34256029-3D150757-A82F-4CCF-8108-472CE90A0DE1 Q34292236-6E13C02F-A168-4CA9-B6E0-087569587C92 Q34465749-C797997E-FE86-464F-9FCF-52CC4F76E15B Q34668723-C09D6530-D674-4167-A4B7-30921174D916 Q34735167-975A077B-6309-419E-A4BA-476004B630FD Q34839826-8786AB26-2E13-4A95-B07A-DA86E4203D83 Q34977042-F497B2DA-8FB2-45CD-98FB-14A9DCE6AF9F Q35005300-2DAAD40C-72E8-40DE-9815-2C1CB409800E Q35049225-4CE40C54-210C-4A15-8033-EE41258341C6 Q35155460-9DA21808-6C75-45C4-8CD6-F19D7B49F8A4 Q35623021-E337CE08-89D0-488F-8A07-38809121C517 Q35675013-25BC3DE6-A454-4BF2-9938-F81C6742B7EC Q36325873-58132477-7618-42F4-BF84-4854C0E6DF51 Q36337755-A5BF62FE-1B55-45E7-A389-B3317BF5CC7D Q36353160-7E28EDB8-672B-498C-A8A3-1F04A265341A Q36463604-8EA13353-47C3-4D5E-99A7-B4E6E5802313 Q36614754-80F559D9-AA80-41D2-BE37-AFE987370D8D Q37130628-8EEC41EA-4B43-4D21-B90E-587217C884D9 Q37131339-6263723D-B6D1-40F6-9D3D-D94E2C97E09D Q37200784-18864F24-3A8E-4540-9F64-B6F1C4354581 Q37284899-1EF3BF94-31A2-4FD5-8311-607A207B4119 Q37326793-CF972BFA-BF71-456C-938C-FE3C68F04A9D Q37388751-8342F1D8-E2C8-4C40-B9D1-731D4D799327 Q37551363-0D1713C9-7CFE-47AF-A795-BEDB6F654342 Q37678826-1B95C29E-AA72-4B3E-8510-0C2BAE686B0C Q37746023-0502F317-0CD8-45D5-890E-5E5A967291A5 Q37764168-A237623C-3E78-4FCD-8346-197305E9B6DD Q37782088-61B36EEA-22E5-4114-8DE4-3C1D3A5BA7A8 Q37809456-BBCCE86D-D569-4BA8-A979-229BC7FA8BD0 Q38004624-65981105-E487-4B1D-B54C-87935748A81F

P2860

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

http://www.wikidata.org/entity/Q35794363

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Identification of typical medu ...... ogeneous new molecular entity.

@ast

Identification of typical medu ...... ogeneous new molecular entity.

@en

type

label

Identification of typical medu ...... ogeneous new molecular entity.

@ast

Identification of typical medu ...... ogeneous new molecular entity.

@en

prefLabel

Identification of typical medu ...... ogeneous new molecular entity.

@ast

Identification of typical medu ...... ogeneous new molecular entity.

@en

P1433

Q35794363-88148166-2513-4107-BEAE-2CCB4C2E5A56

P1476

Q35794363-C6ACBF70-F7C4-4134-944C-0F6330D5F388

P2093

Q35794363-09D9FB45-0C62-438D-A738-A9CDF5378457

Q35794363-17909874-FDE4-4D44-93AB-8E5AEBD019EF

Q35794363-1A2C4AF5-1330-4B35-9B25-0FEEC72A828F

Q35794363-1C597380-F2C8-42E1-A49F-D36595082D1D

Q35794363-2799262D-556C-4C44-9DE0-A7E186E6E32C

Q35794363-4362F79C-4A5F-4001-BE9A-024C1A59B586

Q35794363-45055C65-F508-4C05-886B-06089CE98515

Q35794363-535876BB-95EE-42F4-B48A-8EB1A137FB35

Q35794363-59DEE0A3-5403-4A61-89A1-509B5D56BEF4

Q35794363-620ADD0C-E4C2-4F8D-9209-100CACB184A0

P2860

Q35794363-06B84508-F418-4861-8BE1-BA97A60384D3

Q35794363-06CDA79F-591C-4A49-9242-2A3660D9203D

Q35794363-0B112153-C0FE-401D-8D6A-14A2A376CA65

Q35794363-0FBBCFF3-84B5-48A4-AF7D-DEEBA9D78159

Q35794363-1F2B85A0-6D2D-435A-8353-16D278A1C70E

Q35794363-22AC696B-430B-4CC2-815C-10F236EC1869

Q35794363-2F1AD736-0FF5-4749-BC41-8EE733E27715

Q35794363-325F3472-FB74-44F6-9F48-F6BA21B564C0

Q35794363-33E9B3BD-EA4B-44C9-8532-0C60B1CF92B3

Q35794363-37B0295F-3320-4CB3-B9B1-F0BF57D7E23C

P2888

Q35794363-5B673923-89FE-4525-A2BE-6BAD68036654

P304

Q35794363-A2592C03-875B-45D8-A39F-BE01C8949E8B

P31

Q35794363-38B2CFBA-30CF-4807-AB26-2E2727CBC236

P356

Q35794363-DC44C85A-BC50-48FD-8343-B987EE538BE6

P433

Q35794363-E3589F8B-DC26-4170-BC6B-9F7AD2CAE3DD

P478

Q35794363-D61D81A0-300A-4838-B4BD-EC8C7B54B13E

P50

Q35794363-340E7872-3CD3-4C23-AD70-1C7704126D55

Q35794363-3568045A-F349-42A9-A9E8-64E97434CC76

Q35794363-47EE1E91-1D08-4168-B5B5-8C3FC554341B

Q35794363-650D47D9-B342-4F12-92C2-5E1E3DAB3C25

Q35794363-90C794B4-E651-4D99-B626-101A036F66B6

Q35794363-B27555E5-8283-4D49-8BDE-2ABF37736103

Q35794363-BE55F98B-F7ED-4BBA-A2A1-05A08E8F57FC

Q35794363-D60DF251-11AE-4DB2-BDDA-298758EB532D

P577

Q35794363-E918F85E-F63E-4208-97C0-B3821E9F78A4

P5875

Q35794363-74838E59-0154-4619-BE0D-16BF3278C382

P6179

Q35794363-ABE6C2A6-490D-4284-A24B-0B0912B3838E

P698

Q35794363-E2FC22B9-FFBD-4426-A0D6-9FBF5FFE5E44

P932

Q35794363-2A62CB05-1697-4554-9015-56C51AED4098

P356

P1433

Breast Cancer Research

P1476

Identification of typical medu ...... ogeneous new molecular entity.

@en

P2093

Alain Aurias

http://www.w3.org/2001/XMLSchema#string

Alain Fourquet

http://www.w3.org/2001/XMLSchema#string

Brigitte Sigal-Zafrani

http://www.w3.org/2001/XMLSchema#string

Carlo Lucchesi

http://www.w3.org/2001/XMLSchema#string

Corinne Taris

http://www.w3.org/2001/XMLSchema#string

Gaëlle Pierron

http://www.w3.org/2001/XMLSchema#string

Gaëtan MacGrogan

http://www.w3.org/2001/XMLSchema#string

Isabelle de Mascarel

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Pierga

http://www.w3.org/2001/XMLSchema#string

Michel Longy

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

X chromosomal abnormalities in basal-like human breast cancer

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions.

c-myc amplifications in primary breast carcinomas and their local recurrences.

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study.

P2888

P304

R24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1666

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Stoppa-Lyonnet

Gaëtan MacGrogan

Anne Vincent-Salomon

Isabelle de Mascarel

Xavier Sastre-Garau

Patricia de Cremoux

Brigitte Sigal-Zafrani

Olivier Delattre

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6404577

http://www.w3.org/2001/XMLSchema#string

P6179

1042824689

http://www.w3.org/2001/XMLSchema#string

P698

17417968

http://www.w3.org/2001/XMLSchema#string

P932

1868916

http://www.w3.org/2001/XMLSchema#string